Related Experiment Video
Updated: Jun 1, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Effect of cardiac resynchronization therapy on libido and erectile dysfunction
Ahmet Vural1, Aysen Agacdiken, Umut Celikyurt
1Department of Cardiology, Kocaeli University Medical Faculty, Kocaeli, Turkey.
Clinical Cardiology
|June 4, 2011
Summary
Cardiac resynchronization therapy (CRT) significantly improves sexual function in men with chronic heart failure (HF). This therapy enhances libido and erectile function, positively impacting quality of life for HF patients.
Area of Science:
- Cardiology
- Sexual Medicine
- Medical Devices
Background:
- Chronic heart failure (HF) is a prevalent condition associated with reduced quality of life, including decreased libido and erectile dysfunction (ED).
- The impact of cardiac resynchronization therapy (CRT) on sexual function in HF patients has not been previously investigated.
- Understanding these effects is crucial for comprehensive patient care.
Purpose of the Study:
- To evaluate the efficacy of cardiac resynchronization therapy (CRT) in improving libido and erectile function (ED) in male patients with advanced heart failure (HF).
Main Methods:
- A cohort of 31 male patients with advanced HF undergoing CRT implantation were assessed.
- Libido and ED were evaluated using the Aging Male Symptoms (AMS) rating scale and the Sexual Health Inventory for Men (SHIM) questionnaire, respectively.
- Assessments were conducted before and 6 months after CRT implantation, alongside evaluations of left ventricular ejection fraction (LVEF) and New York Heart Association (NYHA) class.
Main Results:
- CRT significantly improved NYHA class (3.4 to 2.1) and LVEF (18% to 32%) after 6 months (P<0.001 for both).
- A significant increase in SHIM scores and a decrease in AMS scores indicated improved sexual function.
- Improvements in sexual function correlated positively with increased LVEF and improved NYHA class.
Conclusions:
- Cardiac resynchronization therapy (CRT) demonstrably enhances libido and erectile function in male patients suffering from congestive heart failure (HF).
- These improvements in sexual health are directly linked to the therapy's positive effects on left ventricular ejection fraction (LVEF) and overall functional capacity.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...